All sessions by type

Plenary sessions

Thursday, 3 December 2015

Time

Title

Room

17:30 – 19:00

Inaugural Session

Auditorium I

Friday, 4 December 2015

Time

Title

Room

09:00 – 10:00

The State of TB and HIV on the 27th anniversary of World AIDS Day: Panel Discussion (hiv, mdr-tb, tb)

Auditorium I

Saturday, 5 December 2015

Time

Title

Room

09:00 – 10:00

Tackling tuberculosis in key affected populations (cs, tb)

Auditorium I

Sunday, 6 December 2015

Time

Title

Room

09:00 – 10:00

Taxing health-harming products and creating health promotion funds: A win-win health strategy for governments: Panel Discussion (tc, ncds, cs)

Auditorium I

15:15 – 16:15

Closing Session (tb, clh, cs, hiv, lh, mdr-tb, ncds, naps, tc, zoo, res)

Auditorium I

Symposia

Wednesday, 2 December 2015

Time

Title

Room

10:00 – 18:00

WHO Global TB Symposium (clh, mdr-tb, tb, res)

Auditorium I

Friday, 4 December 2015

Time

Title

Room

10:30 – 12:00

01. Bending South Africa's TB curve: game-changing interventions to attain a future of "zeros" | en français (tb)

Auditorium I

10:30 – 12:00

02. Best practice in management of side effects among DR-TB patients to improve quality of care | en français (tb, mdr-tb)

Ballroom East - CTICC

10:30 – 12:00

03. Pre-approval of access to new TB drugs: what, where and how (tb)

Roof Terrace

10:30 – 12:00

04. Outstanding issues in HIV/AIDS (hiv)

Ballroom West - CTICC

10:30 – 12:00

05. ZTB session: Zoonotic tuberculosis: trends, diagnostics and infections model (zoo)

MR 2.41-2.43

10:30 – 12:00

06. One pilot after another: how can we move toward a sustainable scale-up of child lung health interventions? (clh)

MR 2.44-2.46

10:30 – 12:00

07. Role of surgery in management of TB: a promise or redundancy? (tb)

Da Gama/Diaz-Westin

13:30 – 15:00

08. Maternal and infant TB: advancing our understanding of pathogenesis, treatment and prevention (clh, tb)

Roof Terrace

13:30 – 15:00

09. The cost of TB and lung health interventions: methodologies and implications for health systems and patients (lh, tb)

MR 2.41-2.43

13:30 – 15:00

10. Research is needed to increase children's access to drug-resistant TB care (tb, clh, mdr-tb, res)

MR 2.44-2.46

13:30 – 15:00

11. TB surveillance in healthcare workers: challenges and approaches in high-burden, low-resource settings (naps, tb)

MR 2.61-2.63

13:30 – 15:00

12. Managing pharmacovigilance systems: optimising the rational use of new TB medicines and novel regimens (tb)

MR 2.64-2.66

13:30 – 15:00

13. Can mobile technology improve lung health in poorer countries and communities: benefits and opportunities (lh)

Ballroom East-Westin

13:30 – 15:00

14. Spelunking for treasure: searching for candidate biomarkers as prognostic indicators for treatment outcome (tb)

Ballroom West-Westin

15:30 – 17:00

15. TB-HIV epidemiology within the context of national TB prevalence surveys in Africa | en français (hiv, tb)

Auditorium I

15:30 – 17:00

16. Scaling up MDR-TB services in resource-limited settings: progress and challenges from the field | en français (mdr-tb, tb)

Ballroom East-CTICC

15:30 – 17:00

17. Maximizing opportunities for integrating TB services into maternal and child health programmes (clh, tb)

Roof Terrace

15:30 – 17:00

18. Five years of Xpert MTB/RIF implementation: lessons learnt for increasing the impact of future new diagnostics (tb)

Auditorium II

15:30 – 17:00

19. Quality laboratory services and the impact on patient care (tb)

Ballroom West-CTICC

15:30 – 17:00

20. The unaddressed health challenge of TB in prisons: applying End TB Strategy concepts of patient-centred care (naps, tb)

MR 2.41-2.43

15:30 – 17:00

21. TB contact management in children: closing policy-implementation gaps (tb, clh)

MR 2.44-2.46

15:30 – 17:00

22. A community-based approach to reaching the missing "three million" (cs, tb)

MR 2.61-2.63

15:30 – 17:00

23. Moving towards universal access to drug susceptibility testing: progress and challenges (tb)

MR 2.64-2.66

15:30 – 17:00

24. Why and how to use tobacco taxes as funding mechanisms for financing health in low- and middle-income countries (tc)

Ballroom East-Westin

15:30 – 17:00

25. Can tuberculosis immunisation prevent initial infection (not just disease complications)? (tb)

Ballroom West-Westin

15:30 – 17:00

26. WHO/ERS initiative on e/mHealth in tuberculosis and tobacco control (tb, tc)

Da Gama/Diaz-Westin

Saturday, 5 December 2015

Time

Title

Room

10:30 – 12:00

27. Building on emerging knowledge to develop novel regimens for paediatric drug-resistant TB (clh, mdr-tb, tb)

Ballroom West-CTICC

10:30 – 12:00

28. End TB, end MDR-TB (tb, mdr-tb)

MR 2.41-2.43

10:30 – 12:00

29. Pneumonia in children and adults beyond 2015 (clh, lh, ncds)

MR 2.44-2.46

10:30 – 12:00

30. Eliminating the burden of TB in indigenous populations (tb)

MR 2.61-2.63

10:30 – 12:00

31. High-burden, neglected patients: addressing the intersection of tuberculosis and mental disorders (tb, ncds)

MR 2.64-2.66

10:30 – 12:00

32. Does MPOWER empower women? (tc)

Ballroom East-Westin

10:30 – 12:00

33. Modelling to support TB control policy in the era of the End TB Strategy (tb)

Ballroom West-Westin

13:30 – 15:00

34. MDR-TB: a complex disease requiring a comprehensive health system response | en français (mdr-tb, tb)

Ballroom East-CTICC

13:30 – 15:00

35. Controversies and critical issues in clinical trial design for TB (tb, res)

Auditorium II

13:30 – 15:00

36. Innovations to improve the TB-HIV patient experience: from diagnosis to treatment (hiv, tb)

Ballroom West-CTICC

13:30 – 15:00

63. Zoonotic TB session II: What do humans, baboons and livestock have in common? (zoo)

MR 1.41-1.42

13:30 – 15:00

37. Inhaled therapies for tuberculosis (tb)

MR 2.41-2.43

13:30 – 15:00

38. Affordable solutions to indoor air pollution for one-third of the world's population (lh)

MR 2.61-2.63

13:30 – 15:00

39. Taking stock of TB epidemiological assessments: experience, lessons learned and the way forward (tb)

MR 2.64-2.66

13:30 – 15:00

40. Reinforcing research for TB elimination at the country level: experiences from path-finding countries (tb, res)

Ballroom West-Westin

15:30 – 17:00

41. The Union/CDC Late-breaker Session on TB | en français (tb, res)

Auditorium I

15:30 – 17:00

42. TB research and communities: ethical and practical considerations | en français (tb, res, cs)

Ballroom East-CTICC

15:30 – 17:00

43. Country experiences: enablers for community-based multidrug-resistant tuberculosis management programmes (mdr-tb, cs, tb)

Roof Terrace

15:30 – 17:00

44. Achieving quality Xpert MTB/RIF use for rapid case detection (tb)

Auditorium II

15:30 – 17:00

45. Finding better treatments sooner: innovations in clinical trials for new regimens beyond 2015 (res, tb)

Ballroom West-CTICC

15:30 – 17:00

46. Strengthening community systems: building the evidence for impact (tb, cs)

MR 2.41-2.43

15:30 – 17:00

47. Getting patients treated for latent TB infection (LTBI) as TB prevention (tb)

MR 2.44-2.46

15:30 – 17:00

48. Beyond accelerated drug development: building successful partnerships and platforms as a critical path to TB drug regimens and PreDiCT-TB (tb, res)

MR 2.61-2.63

15:30 – 17:00

49. Sanatoria: back to the future? (tb)

MR 2.64-2.66

15:30 – 17:00

50. Smokeless tobacco: a silent killer (tc)

Ballroom East-Westin

15:30 – 17:00

51. e/m-Health as a transformational tool in TB control in high-burden countries (tb)

Ballroom West-Westin

15:30 – 17:00

52. Developing a rights-based approach to prevention and treatment of tuberculosis (cs, tb)

Da Gama/Diaz-Westin

Sunday, 6 December 2015

Time

Title

Room

10:30 – 12:00

53. Fighting TB in the post-2015 era: paradigm shift in strategies and plans to put an end to TB | en français (cs, tb)

Auditorium I

10:30 – 12:00

54. Critical updates on the treatment of TB-HIV co-infected children (clh, hiv, tb)

MR 2.44-2.46

10:30 – 12:00

55. Why are DR-TB patients lost by TB programmes? Patients’ perspective on how to address DR-TB treatment adherence (mdr-tb)

MR 2.61-2.63

10:30 – 12:00

56. The relationship between gender and specific tobacco products, tobacco consumption and inequalities (tc)

Ballroom East-Westin

10:30 – 12:00

57. The role of cost-effectiveness in achieving the End TB Strategy (tb)

Ballroom West-Westin

10:30 – 12:00

58. Universal health coverage and insurance: how TB fits into the health financing picture (tb)

Da Gama/Diaz-Westin

13:30 – 15:00

59. HIV/TB Late-Breaker Session | en français (hiv, tb, res)

Auditorium I

13:30 – 15:00

60. Moving past clinic-based care: practical steps to improve TB care through community engagement | en français (cs, tb)

Ballroom East-CTICC

13:30 – 15:00

61. Progress in clinical trials for TB treatment: 2015 (res, tb)

Roof Terrace

13:30 – 15:00

62. Innovative approach to improving access and quality of care for DR-TB: implementing the ECHO telehealth model (mdr-tb, tb)

Auditorium II

63. See 5 December

13:30 – 15:00

64. TB contact investigation in high-risk populations: innovative approaches and implementation experiences (tb)

Ballroom East-Westin

13:30 – 15:00

65. The XDR experience: clinician and patient perspectives on treatment and care (cs, mdr-tb, tb)

Ballroom West-Westin

E-poster sessions

Friday, 4 December 2015

Time

Title

Room

12:30 – 13:30

01. Zoonotic tuberculosis: trends, detections and interpretation (zoo)

Poster Area

12:30 – 13:30

02. TB in children: perspectives from around the world (clh)

Poster Area

12:30 – 13:30

03. Drug-resistant TB: outcomes - I (mdr-tb, tb)

Poster Area

12:30 – 13:30

04. LTBI: a potpourri (tb)

Poster Area

12:30 – 13:30

05. Rats, videos and secretions: the landscape of TB detection (tb)

Poster Area

Saturday, 5 December 2015

Time

Title

Room

12:30 – 13:30

06. Preventing infection and transmission of TB in health facilities and the community (tb)

Poster Area

12:30 – 13:30

07. The rainbow session: treatment vaccination, surveillance or tuberculosis and everything in between (tb)

Poster Area

12:30 – 13:30

08. High-definition insights into drug-resistant tuberculosis (mdr-tb, tb)

Poster Area

12:30 – 13:30

09. Behind bars: TB in correctional settings - II (tb)

Poster Area

12:30 – 13:30

10. The neglected cousins: trends and treatment of non-tuberculous mycobacteria (tb, hiv)

Poster Area

Sunday, 6 December 2015

Time

Title

Room

12:15 – 13:15

11. m-health solutions (tb)

Poster Area

12:15 – 13:15

12. Pneumonia and indoor air pollution (ncds, lh)

Poster Area

12:15 – 13:15

13. Case finding and contact tracing (tb)

Poster Area

12:15 – 13:15

14. Sniffing out TB: from nose to immunochemistry (tb)

Poster Area

12:15 – 13:15

15. From TB diagnosis to outcomes, and everything in between (tb, hiv)

Poster Area

Poster discussion sessions

Friday, 4 December 2015

Time

Title

Room

12:30 – 13:30

01. Extra-pulmonary tuberculosis: detection and treatment (tb)

Poster Area

12:30 – 13:30

02. Drug development: something old, something new (tb)

Poster Area

12:30 – 13:30

03. Treatment outcomes and ethics: bedaquiline (mdr-tb, tb)

Poster Area

12:30 – 13:30

04. New approaches to health systems, care and management for drug-resistant TB (mdr-tb, tb)

Poster Area

12:30 – 13:30

05. Collaborative services for TB and diabetes (tb, ncds)

Poster Area

12:30 – 13:30

06. TB surveillance from Swaziland to Japan (tb)

Poster Area

12:30 – 13:30

07. Tuberculosis: from the bench to the grave (tb)

Poster Area

12:30 – 13:30

08. Trends, transmission and tuberculosis case finding (tb)

Poster Area

12:30 – 13:30

09. Public-private strategies to End TB: the case of India (tb, cs)

Poster Area

12:30 – 13:30

10. What's app doc? Use of m-health (tb)

Poster Area

12:30 – 13:30

11. Basic science: bugs and drugs (tb)

Poster Area

12:30 – 13:30

12. TB diagnostic challenges: molecular and other techniques (tb)

Poster Area

12:30 – 13:30

13. Diverse diagnostics (tb)

Poster Area

12:30 – 13:30

14. Gene mutation: the engine behind drug resistance and TB strain diversity (mdr-tb, tb)

Poster Area

12:30 – 13:30

15. Gene Xpert: the nuts and bolts of TB diagnosis (tb, mdr-tb)

Poster Area

12:30 – 13:30

16. Retaining our patients in care (naps, tb)

Poster Area

12:30 – 13:30

17. Including those affected in care (cs, naps, tb)

Poster Area

12:30 – 13:30

18. Don't forget us: migrants and indigenous populations (cs, tb)

Poster Area

12:30 – 13:30

19. TB in children: epidemiology - I (clh, tb)

Poster Area

12:30 – 13:30

20. TB in children: diagnosis (clh, tb)

Poster Area

12:30 – 13:30

21. COPD, lung function and pulmonary embolism (lh, ncds)

Poster Area

12:30 – 13:30

22. Smoking cessation (lh, tc)

Poster Area

12:30 – 13:30

23. Social media campaigns (cs, tc)

Poster Area

12:30 – 13:30

24. Engagement of CSOs, communities and patients in TB control and management (cs, tb)

Poster Area

12:30 – 13:30

25. HIV and lung health: something for everyone (hiv, lh)

Poster Area

Saturday, 5 December 2015

Time

Title

Room

12:30 – 13:30

26. TART: TB risk and impact of ART (hiv, tb)

Poster Area

12:30 – 13:30

27. Drug-resistant TB: outcomes (mdr-tb, tb)

Poster Area

12:30 – 13:30

28. Drug-resistant TB: epidemiology and transmission (mdr-tb, tb)

Poster Area

12:30 – 13:30

29. LTBI testing, perceptions and epidemiology (tb)

Poster Area

12:30 – 13:30

30. Collaborative services for TB and diabetes (tb)

Poster Area

12:30 – 13:30

31. Spatial epidemiology of tuberculosis (tb)

Poster Area

12:30 – 13:30

32. The game of numbers: prevalence and incidence of tuberculosis (tb)

Poster Area

12:30 – 13:30

33. Molecules, polymorphisms and resistance to TB (tb)

Poster Area

12:30 – 13:30

34. Thinking broadly to advance the END TB Strategy (tb)

Poster Area

12:30 – 13:30

35. Financial impact of TB (tb)

Poster Area

12:30 – 13:30

36. Molecular diagnostics: pitfalls and improvements (tb)

Poster Area

12:30 – 13:30

37. Rapid diagnosis the world over (tb)

Poster Area

12:30 – 13:30

38. Phenotypes and genotypes: deciphering resistance development (mdr-tb, tb)

Poster Area

12:30 – 13:30

39. Tuberculosis drug resistance and susceptibility testing in a nutshell (mdr-tb, tb)

Poster Area

12:30 – 13:30

40. From safety to supply-chain: let's talk lab management (tb)

Poster Area

12:30 – 13:30

41. Stepping up patient access and support (cs, naps, tb)

Poster Area

12:30 – 13:30

42. Inside the belly of the beast: TB in correctional settings (tb)

Poster Area

12:30 – 13:30

43. The urban-rural divide: different places, similar issues (tb)

Poster Area

12:30 – 13:30

44. Paediatric TB: MDR (clh, mdr-tb)

Poster Area

12:30 – 13:30

45. Paediatric TB: training, BCG and pharmacokinetics (clh)

Poster Area

12:30 – 13:30

46. Harmful effects of second-hand smoke (tc)

Poster Area

12:30 – 13:30

47. Monitoring the tobacco industry: promotion and advertisements (tc)

Poster Area

12:30 – 13:30

48. Enforcement of smoke-free legislation (tc)

Poster Area

12:30 – 13:30

49. Strategies to improve TB-HIV screening and service integration (hiv, tb)

Poster Area

Sunday, 6 December 2015

Time

Title

Room

12:15 – 13:15

50. TB tidbits: diagnosis, surgery and outcomes (tb)

Poster Area

12:15 – 13:15

51. M/XDR treatment: toxicity and stigma (mdr-tb, tb)

Poster Area

12:15 – 13:15

52. Community-based and self-administered treatment of drug-resistant TB (mdr-tb, tb)

Poster Area

12:15 – 13:15

53. Infection control (tb)

Poster Area

12:15 – 13:15

54. TB and nutrition (tb)

Poster Area

12:15 – 13:15

55. Molecular epidemiology and modelling: how can we break the cycle of transmission? (tb)

Poster Area

12:15 – 13:15

56. Tbilisi to Lima: a journey through TB treatment outcomes (tb)

Poster Area

12:15 – 13:15

57. When the tail wags the dog: drug resistance in TB programmes (mdr-tb, tb)

Poster Area

12:15 – 13:15

58. Advancing the END TB strategy and other policy issues (tb)

Poster Area

12:15 – 13:15

59. Basic science: host (tb)

Poster Area

12:15 – 13:15

60. Imagining and prediction rules for TB diagnosis (tb)

Poster Area

12:15 – 13:15

61. Alternative diagnostics for drug resistance (mdr-tb, tb)

Poster Area

12:15 – 13:15

62. Insights into drug-resistant tuberculosis from Ghana to Peru (mdr-tb, tb)

Poster Area

12:15 – 13:15

63. MDR-TB: detection, prevalence, and drivers (mdr-tb, tb)

Poster Area

12:15 – 13:15

64. Patient-centered care and methods to improve treatment adherence (tb)

Poster Area

12:15 – 13:15

65. Why are you late? Delay in treatment access (tb)

Poster Area

12:15 – 13:15

66. Gender issues in TB and tobacco (tb, tc)

Poster Area

12:15 – 13:15

67. The spectrum of life: miners, drug users, the elderly (tb)

Poster Area

12:15 – 13:15

68. Paediatric TB: IPT, contact tracing and child perspectives (clh, tb)

Poster Area

12:15 – 13:15

69. Paediatric TB: epidemiology - II (clh, tb)

Poster Area

12:15 – 13:15

70. The 2 'Ts': linking TB and tobacco (tc, tb)

Poster Area

12:15 – 13:15

71. From old to new: shisha to e-cigarettes (tc)

Poster Area

12:15 – 13:15

72. Holding hands: high-level cooperation on tobacco control (tc)

Poster Area

12:15 – 13:15

73. IPT: attitudes, application and adherence (hiv, tb)

Poster Area

Oral abstract sessions

Friday, 4 December 2015

Time

Title

Room

10:30 – 12:00

01. Symptoms, sputum, sequence: TB diagnosis and resistance (tb, mdr-tb)

Auditorium II

10:30 – 12:00

02. Around the world vulnerability takes many forms (cs, tb)

MR 2.61 - 2.63

10:30 – 12:00

03. Placing the patient at the centre of care (tb, cs, naps)

MR 2.64 - 2.66

10:30 – 12:00

04. Law enforcement and awareness (tb, cs)

Ballroom East-Westin

10:30 – 12:00

05. Financing TB services (cs, tb)

Ballroom West-Westin

13:30 – 15:00

06. MDR-TB: trials, cohorts and predictors | en français (mdr-tb, tb)

Auditorium I

13:30 – 15:00

07. Many paths to the same END TB strategy | en français (tb)

Ballroom East-CTICC

13:30 – 15:00

08. The molecular basis of PZA resistance: from bench to bedside (mdr-tb, tb)

Auditorium II

13:30 – 15:00

09. HIV and lung health (hiv, lh, tb)

Ballroom West-CTICC

13:30 – 15:00

10. Using media for communications on TB (cs, tb)

Da Gama/Diaz-Westin

Saturday, 5 December 2015

Time

Title

Room

10:30 – 12:00

11. Improving TB treatment outcomes | en français (tb)

Auditorium I

10:30 – 12:00

12. MDR-TB: impacts of detection and early treatment | en français (mdr-tb, tb)

Ballroom East-CTICC

10:30 – 12:00

13. LTBI in high- and low-burden settings (tb)

Roof Terrace

10:30 – 12:00

14. From specimens to outcome: new information for molecular diagnosis (tb)

Auditorium I

10:30 – 12:00

15. When waves trump paper: the triumph of e-technology (tb)

Da Gama/Diaz-Westin

13:30 – 15:00

16. From bench to treatment | en français (mdr-tb, tb)

Auditorium I

13:30 – 15:00

17. TB & NCD co-morbidity (tb)

Roof Terrace

13:30 – 15:00

18. TB in children: diagnosis prevention and best practice (clh, tb)

MR 2.44 - 2.46

13:30 – 15:00

19. Tobacco: economics and illicit trade (tc)

Ballroom East-Westin

13:30 – 15:00

20. IAP, pneumonia, asthma and chronic lung disease (lh, ncds)

Da Gama/Diaz-Westin

Sunday, 6 December 2015

Time

Title

Room

10:30 – 12:00

21. TB epidemiology: post and future insights into case finding, drug resistance | en français (mdr-tb, tb)

Ballroom East-CTICC

13:30 – 15:00

22. The nature of the beast: emerging molecular information about mycobacteria (res, tb)

Ballroom West-CTICC

13:30 – 15:00

23. TB in children, including MDR (clh, mdr-tb, tb)

MR 2.44 - 2.46

13:30 – 15:00

24. The wide swath of vulnerable populations (cs)

MR 2.61 - 2.63

13:30 – 15:00

25. Engagement of CSOs, communities and patients in TB management and control (cs, tb)

MR 2.64 - 2.66

13:30 – 15:00

26. Lung health: pneumonia, COPD, asthma and cystic fibrosis (lh, ncds)

Da Gama/Diaz-Westin

Short Oral Abstract Session

Sunday, 6 December 2015

Time

Title

Room

10:30 – 12:00

01. Across the spectrum of TB management (mdr-tb, tb)

Roof Terrace

10:30 – 12:00

02. How to reach the END of TB (tb)

Auditorium II

10:30 – 12:00

03. HIV and TB: snapshots (hiv, tb)

Ballroom West-CTICC

10:30 – 12:00

04. TB epidemiology: from Malawi to Taiwan (tb)

MR 2.41-2.43

10:30 – 12:00

05. Training for the fight against TB (mdr-tb, tb)

MR 2.64-2.66

Meet-the-expert sessions

Saturday, 5 December 2015

Time

Title

Room

08:00 – 08:50

1. The use of our first line drugs in children – Peter Donald (South Africa) (clh)

MR 2.41-2.43

08:00 – 08:50

2.1 From the recent literature on HIV – Stephen Lawn (UK) (hiv, tb)

MR 2.44–2.46

08:00 – 08:50

3. Vaccine development - Mark Hatherill (South Africa) (hiv, clh, tb)

MR 2.61-2.63

08:00 – 08:50

4. Tobacco industry interference with tobacco control – Lekhan Ayo-Yusuf (South Africa) (tc)

MR 2.64–2.66

08:00 – 08:50

5. Nurse-initiated MDR-TB treatment - Khaya Mlandu (South Africa) (mdr-tb, naps)

Da Gama/Diaz - Westin

Sunday, 6 December 2015

Time

Title

Room

08:00 – 08:50

6. Advocacy and advocates: What is it? Who are they? - Muyabala Munachitombwe-Muna (Swaziland), Evaline Kibuchi (Kenya) (cs)

MR 2.44–2.46

08:00 – 08:50

7. Tuberculosis infection control - Virginia Lipke (Switzerland), Max Meis (Netherlands) (tb)

MR 2.61–2.63

08:00 – 08:50

8. Highlights and updates of diagnostic research for tuberculosis: where are we, what next? – Grant Theron (South Africa) (tb, res)

MR 2.64–2.66

08:00 – 08:50

2.2 From the recent literature on HIV – Robin Wood (South Africa) (hiv)

Post-graduate courses

Wednesday, 2 December 2015

Time

Title

Room

09:00 – 16:00

01. Project management

Auditorium II

09:00 – 16:00

02. Best practices in the management of the second-line injectable drugs in children with multidrug-resistant TB (clh, mdr-tb)

MR 1.41

09:00 – 16:00

03. Qualitative methods in global tuberculosis research (tb, res)

MR 1.42

09:00 – 16:00

04. An introduction to tuberculosis modelling (TB Modelling and Analysis Consortium) (tb)

MR 1.43

09:00 – 16:00

05. Skill building for health educators (naps)

Thursday, 3 December 2015

Time

Title

Room

09:00 – 16:00

06. Implementing new and re-purposed drugs for the treatment of drug-resistant TB: lessons from the field (mdr-tb, tb)

Ballroom West-CTICC

09:00 – 16:00

07. Update on clinical and programmatic management of MDR- and XDR-TB (mdr-tb, tb)

MR 2.64-2.66

09:00 – 12:00

08. Integrating palliative care into the continuum of MDR-TB Care (mdr-tb, naps, tb)

MR 1.42

13:00 – 16:00

09. Establishing community MDR-TB programmes (tb, cs)

MR 1.42

09:00 – 16:00

10. Making sense and use of routine TB data for management (tb)

MR 1.43

09:00 – 16:00

11. Risk factor management and tuberculosis control (tb)

09:00 – 16:00

12. Key components of effective and sustainable tuberculosis infection control programme (tb)

Marco Polo-Westin

09:00 – 16:00

13. Strengthening TB case finding and prevention in high-risk populations (tb)

Sir Francis Drake-Westin

Workshops

Wednesday, 2 December 2015

Time

Title

Room

09:00 – 16:00

01. Operational research skills in one day (res)

Auditorium II

09:00 – 16:00

02. Building new treatment paradigms for TB programmes using PK/PD science (tb)

Ballroom West-CTICC

09:00 – 16:00

03. Developing counselling skill for TB caregivers in one day (tb, naps)

MR 2.41-2.43

09:00 – 12:00

04. Adding connectivity to your TB diagnostics (tb)

Roof Terrace

13:00 – 16:00

05. Challenges in setting up phase 2/3 MDR-TB clinical trials (mdr-tb, tb, res)

Roof Terrace

Thursday, 3 December 2015

Time

Title

Room

09:00 – 16:00

06. Ensuring MDR-TB patient information and adherence counselling is a key part of patient-centred care (tb, naps, mdr-tb)

Auditorium II

09:00 – 16:00

07. The Global Fund’s new funding model: country experiences of moving toward grant implementation (hiv, tb)

Ballroom East-CTICC

09:00 – 16:00

08. WHO consolidated guidelines for treatment of tuberculosis (tb)

MR 2.41-2.43

09:00 – 16:00

09. Post-2015 GTB technical support coordination for Global Fund grants and concept notes for End TB Strategy (tb)

09:00 – 12:00

10. Application of programme guidelines for community-driven projects to eliminate TB among migrants (tb, cs)

MR 2.44-2.46

13:00 – 16:00

11. Towards a community and patient-centred movement (cs, naps)

MR 1.44

09:00 – 12:00

12. Monitoring & evaluation in active case finding: the TB REACH approach (tb)

Ballroom East-Westin

13:00 – 16:00

13. Challenges of DR-TB treatment in India and opportunities beyond 2015: patient voices from India (cs, tb, mdr-tb)

Ballroom East-Westin

09:00 – 16:00

14. Access to TB medicines beyond 2015: the dynamics of demand and supply (tb)

Ballroom West-Westin

09:00 – 16:00

15. Molecular diagnostics: bringing together the basic science and clinical worlds (tb, res)

MR 2.61-2.63

09:00 – 16:00

16. Pharmacovigilance for bedaquiline, delamanid and other TB drugs and regimens (tb)

Sir Francis Drake-Westin

09:00 – 16:00

17. Budgeting for TB care and control in an integrated fashion: one-day OneHealth tool introduction (tb)

All sessions by type

Topics Legend